News search
|
Research 22 May 2026 A CNIC-led study identifies a mitochondrial “checkpoint” that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumors |
|
Research 30 Apr 2026 Faseeha Ayaz, senior Editor Nature Communications, Springer Nature |
|
About the CNIC 5 Mar 2026 Justin Perry, Associate Member in the Immunology Program of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center and an Assistant Professor in the Immunology and Microbial Pathogenesis Program at Weill Cornell Medical Center |
|
Research 16 Feb 2026 A new CNIC-led study shows that a genetic tool derived from baker’s yeast enables human cells to manufacture the building blocks of DNA even when their mitochondria fail. |
|
Research 2 Dec 2025 An international team has published NeuMap, the first atlas to reveal the global architecture of neutrophils, showing how this “first line of defense” reorganizes to protect, remember, and heal. |
|
Research 16 Jul 2025 A new study led by the CNIC has identified imidazole propionate (ImP), a metabolite produced by gut bacteria, as a driver of atherosclerosis— as a driver of atherosclerosis, the disease behind most heart attacks and strokes |
|
Research 5 Jun 2025 This new tool will advance the development of treatments for congenital muscle diseases and cardiomyopathies. |
|
About the CNIC 30 Apr 2025 Dr. Jonathan Kipnis is a Principal Investigator and the Alan A. and Edith L. Wolff Distinguished Professor of Pathology and Immunology at Washington University |
|
Research 14 Apr 2025 A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with the Instituto de Investigación Biomédica de Barcelona (IRB Barcelona), has identified the most effective subtype of dendritic cell for generating immune memory in response to cancer |
|
Research 19 Mar 2025 Nature: CNIC scientists discover a type of immune cell that produces defensive "shields" in the skin The discovery, published in Nature, opens the path to new strategies for treating skin diseases and immunological disorders, with special potential for the treatment of inflammation, diabetes, and age-related conditions |
- 1 of 8
- next ›
















